389 related articles for article (PubMed ID: 28605348)
1. Essential Mechanisms of Differential Activation of Eosinophils by IL-3 Compared to GM-CSF and IL-5.
Esnault S; Kelly EA
Crit Rev Immunol; 2016; 36(5):429-444. PubMed ID: 28605348
[TBL] [Abstract][Full Text] [Related]
2. IL-3 Maintains Activation of the p90S6K/RPS6 Pathway and Increases Translation in Human Eosinophils.
Esnault S; Kelly EA; Shen ZJ; Johansson MW; Malter JS; Jarjour NN
J Immunol; 2015 Sep; 195(6):2529-39. PubMed ID: 26276876
[TBL] [Abstract][Full Text] [Related]
3. Human Eosinophils Express a Distinct Gene Expression Program in Response to IL-3 Compared with Common β-Chain Cytokines IL-5 and GM-CSF.
Nelson RK; Brickner H; Panwar B; Ramírez-Suástegui C; Herrera-de la Mata S; Liu N; Diaz D; Alexander LEC; Ay F; Vijayanand P; Seumois G; Akuthota P
J Immunol; 2019 Jul; 203(2):329-337. PubMed ID: 31175163
[TBL] [Abstract][Full Text] [Related]
4. Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience.
Varricchi G; Bagnasco D; Ferrando M; Puggioni F; Passalacqua G; Canonica GW
Ther Adv Respir Dis; 2017 Jan; 11(1):40-45. PubMed ID: 27856823
[TBL] [Abstract][Full Text] [Related]
5. New approaches in the treatment of asthma.
Ramshaw HS; Woodcock JM; Bagley CJ; McClure BJ; Hercus TR; Lopez AF
Immunol Cell Biol; 2001 Apr; 79(2):154-9. PubMed ID: 11264710
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of blood mononuclear cells of atopic children with the relevant allergen induces the release of eosinophil chemotaxins such as IL-3, IL-5, and GM-CSF.
Lantero S; Sacco O; Scala C; Rossi GA
J Asthma; 1997; 34(2):141-52. PubMed ID: 9088301
[TBL] [Abstract][Full Text] [Related]
7. Expression of eosinophil β chain-signaling cytokines receptors, outer-membrane integrins, and type 2 inflammation biomarkers in severe non-allergic eosinophilic asthma.
Kalinauskaite-Zukauske V; Januskevicius A; Janulaityte I; Miliauskas S; Malakauskas K
BMC Pulm Med; 2019 Aug; 19(1):158. PubMed ID: 31438916
[TBL] [Abstract][Full Text] [Related]
8. Activation of human eosinophil and neutrophil functions by haematopoietic growth factors: comparisons of IL-1, IL-3, IL-5 and GM-CSF.
Fabian I; Kletter Y; Mor S; Geller-Bernstein C; Ben-Yaakov M; Volovitz B; Golde DW
Br J Haematol; 1992 Feb; 80(2):137-43. PubMed ID: 1550768
[TBL] [Abstract][Full Text] [Related]
9. CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors.
Panousis C; Dhagat U; Edwards KM; Rayzman V; Hardy MP; Braley H; Gauvreau GM; Hercus TR; Smith S; Sehmi R; McMillan L; Dottore M; McClure BJ; Fabri LJ; Vairo G; Lopez AF; Parker MW; Nash AD; Wilson NJ; Wilson MJ; Owczarek CM
MAbs; 2016; 8(3):436-53. PubMed ID: 26651396
[TBL] [Abstract][Full Text] [Related]
10. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.
Heinisch IV; Bizer C; Volgger W; Simon HU
J Allergy Clin Immunol; 2001 Jul; 108(1):21-8. PubMed ID: 11447378
[TBL] [Abstract][Full Text] [Related]
11. Involvement and Possible Role of Eosinophils in Asthma Exacerbation.
Nakagome K; Nagata M
Front Immunol; 2018; 9():2220. PubMed ID: 30323811
[TBL] [Abstract][Full Text] [Related]
12. Delayed eosinophil apoptosis in asthma.
Kankaanranta H; Lindsay MA; Giembycz MA; Zhang X; Moilanen E; Barnes PJ
J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):77-83. PubMed ID: 10887309
[TBL] [Abstract][Full Text] [Related]
13. Humoral regulation of eosinophilopoiesis in vitro: analysis of the targets of interleukin-3, granulocyte/macrophage colony-stimulating factor (GM-CSF), and interleukin-5.
Sonoda Y; Arai N; Ogawa M
Leukemia; 1989 Jan; 3(1):14-8. PubMed ID: 2642572
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-3-induced up-regulation of CR3 expression on human eosinophils is inhibited by dexamethasone.
Hartnell A; Kay AB; Wardlaw AJ
Immunology; 1992 Dec; 77(4):488-93. PubMed ID: 1493920
[TBL] [Abstract][Full Text] [Related]
15. The effect of transendothelial migration on eosinophil function.
Yamamoto H; Sedgwick JB; Vrtis RF; Busse WW
Am J Respir Cell Mol Biol; 2000 Sep; 23(3):379-88. PubMed ID: 10970830
[TBL] [Abstract][Full Text] [Related]
16. The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: Asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis.
Nagase H; Ueki S; Fujieda S
Allergol Int; 2020 Apr; 69(2):178-186. PubMed ID: 32139163
[TBL] [Abstract][Full Text] [Related]
17. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases.
Schmid-Grendelmeier P; Altznauer F; Fischer B; Bizer C; Straumann A; Menz G; Blaser K; Wüthrich B; Simon HU
J Immunol; 2002 Jul; 169(2):1021-7. PubMed ID: 12097410
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma.
Wallaert B; Desreumaux P; Copin MC; Tillie I; Benard A; Colombel JF; Gosselin B; Tonnel AB; Janin A
J Exp Med; 1995 Dec; 182(6):1897-904. PubMed ID: 7500035
[TBL] [Abstract][Full Text] [Related]
19. Potential contribution of IL-7 to allergen-induced eosinophilic airway inflammation in asthma.
Kelly EA; Koziol-White CJ; Clay KJ; Liu LY; Bates ME; Bertics PJ; Jarjour NN
J Immunol; 2009 Feb; 182(3):1404-10. PubMed ID: 19155487
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome.
Schrezenmeier H; Thomé SD; Tewald F; Fleischer B; Raghavachar A
Exp Hematol; 1993 Feb; 21(2):358-65. PubMed ID: 8425573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
